Published in Kidney Res Clin Pract on January 18, 2012
The nuclear receptor superfamily: the second decade. Cell (1995) 24.99
Vitamin D deficiency and risk of cardiovascular disease. Circulation (2008) 13.39
Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis (1998) 10.70
Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr (2004) 9.01
Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int (2006) 6.61
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med (2003) 6.41
Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int (2009) 5.43
Myc stimulates nuclearly encoded mitochondrial genes and mitochondrial biogenesis. Mol Cell Biol (2005) 4.99
Vitamin D. Am J Physiol Renal Physiol (2005) 4.81
A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res (2010) 4.77
Genetics and biology of vitamin D receptor polymorphisms. Gene (2004) 4.60
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol (2005) 4.44
The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res (1998) 4.27
Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A (1988) 4.23
Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes (2008) 4.11
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med (1997) 3.91
Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int (2006) 3.63
Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab (2001) 3.51
Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis (2004) 3.34
Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab (2003) 3.22
An international comparison of serum 25-hydroxyvitamin D measurements. Osteoporos Int (1999) 3.07
Ultraviolet light may contribute to geographic and racial blood pressure differences. Hypertension (1997) 3.06
Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int (2008) 2.95
Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation (2009) 2.85
Ultraviolet B and blood pressure. Lancet (1998) 2.83
Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J Am Soc Nephrol (2002) 2.58
Target cells for 1,25-dihydroxyvitamin D3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science (1979) 2.57
Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals. Proc Natl Acad Sci U S A (2007) 2.25
Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis (1996) 2.22
Treatment with pyrophosphate inhibits uremic vascular calcification. Kidney Int (2010) 2.16
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin Endocrinol (Oxf) (2009) 1.87
Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A (1985) 1.86
Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells. Cancer Res (1994) 1.85
Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men. Am J Hypertens (1995) 1.85
Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis (2011) 1.83
Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse. J Steroid Biochem Mol Biol (2006) 1.82
Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2000) 1.82
1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte. J Steroid Biochem Mol Biol (2006) 1.73
Vitamin D deficiency is associated with sudden cardiac death, combined cardiovascular events, and mortality in haemodialysis patients. Eur Heart J (2010) 1.72
Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care (2011) 1.67
1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest (1996) 1.65
Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis (1999) 1.63
Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology (2008) 1.58
Association of calcitriol and blood pressure in normotensive men. Hypertension (1997) 1.57
Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis (2011) 1.55
Metabolism of vitamin D3 by cytochromes P450. Front Biosci (2005) 1.52
The prevalence of hypovitaminosis D and secondary hyperparathyroidism in obese Black Americans. Clin Endocrinol (Oxf) (2006) 1.50
Pathways for kidney-specific uptake of the steroid hormone 25-hydroxyvitamin D3. Curr Opin Lipidol (2002) 1.50
Association of serum alkaline phosphatase with coronary artery calcification in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2009) 1.50
Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res (1988) 1.46
BMP-7 is an efficacious treatment of vascular calcification in a murine model of atherosclerosis and chronic renal failure. J Am Soc Nephrol (2003) 1.45
Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens (1990) 1.35
Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis. Hemodial Int (2007) 1.32
Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol (1995) 1.29
Dysregulation of renal vitamin D metabolism in the uremic rat. Kidney Int (2010) 1.27
Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.26
Ratio of paricalcitol dosage to serum parathyroid hormone level and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2008) 1.24
Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem (2004) 1.24
Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis (2011) 1.23
Immunocytochemical detection of 1,25-dihydroxyvitamin D receptors in normal human tissues. J Clin Endocrinol Metab (1988) 1.22
Assessing vitamin D status: pitfalls for the unwary. Mol Nutr Food Res (2010) 1.21
Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens (1989) 1.21
Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2010) 1.20
1,25-dihydroxyvitamin D3 and 9-cis-retinoic acid act synergistically to inhibit the growth of LNCaP prostate cells and cause accumulation of cells in G1. Endocrinology (1997) 1.19
Clinical relevance of FGF-23 in chronic kidney disease. Kidney Int Suppl (2009) 1.18
Hair follicle expression of 1,25-dihydroxyvitamin D3 receptors during the murine hair cycle. Br J Dermatol (1994) 1.18
Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J (2011) 1.16
Vitamin D insufficiency is associated with impaired vascular endothelial and smooth muscle function and hypertension in young rats. J Physiol (2011) 1.15
Arterial stiffness in mild primary hyperparathyroidism. J Clin Endocrinol Metab (2005) 1.12
Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium. Am J Physiol (1996) 1.12
Endothelial vasodilatory dysfunction in primary hyperparathyroidism is reversed after parathyroidectomy. Surgery (1999) 1.11
Myocardial dysfunction due to hypocalcemia. Indian Pediatr (2010) 1.10
Effect of cholecalciferol treatment on the relaxant responses of spontaneously hypertensive rat arteries to acetylcholine. Hypertension (1999) 1.09
Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut (1992) 1.08
Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) (2009) 1.07
Vitamin D-dependent recruitment of corepressors to vitamin D/retinoid X receptor heterodimers. Mol Cell Biol (2008) 1.07
Measurement of vitamin D status: background, clinical use, and methodologies. Clin Lab (2006) 1.05
The vitamin D receptor gene is associated with Alzheimer's disease. Neurosci Lett (2011) 1.05
Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Am J Nephrol (2007) 1.04
Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS One (2009) 1.04
Effectiveness of 1,25-dihydroxyvitamin D supplementation on blood pressure reduction in a pseudohypoparathyroidism patient with high renin activity. Intern Med (1999) 1.04
Antiproliferative responses to two human colon cancer cell lines to vitamin D3 are differently modified by 9-cis-retinoic acid. Cancer Res (1996) 1.02
Vitamin D in chronic kidney disease. Best Pract Res Clin Endocrinol Metab (2011) 0.99
Calcium metabolism in elderly hypertensive patients: possible participation of exaggerated sodium, calcium and phosphate excretion. Clin Exp Pharmacol Physiol (1991) 0.98
Prediabetes and prehypertension in healthy adults are associated with low vitamin D levels. Diabetes Care (2011) 0.97
Risk factors of one year increment of coronary calcifications and survival in hemodialysis patients. BMC Nephrol (2010) 0.95
1,25-Dihydroxyvitamin D3 regulation of myocardial growth and c-myc levels in the rat heart. Biochem Biophys Res Commun (1995) 0.95
No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial. Kidney Int (2011) 0.95
Vitamin D receptor found in human sperm. Urology (2006) 0.93
Differential effects of 1,25-dihydroxyvitamin D3 and tetradecanoylphorbol acetate on cell cycle and apoptosis of MCF-7 cells and a vitamin D3-resistant variant. Endocrinology (1997) 0.92
Myocardial effects of VDR activators in renal failure. J Steroid Biochem Mol Biol (2010) 0.92
The down-regulation of the human MYC gene by the nuclear hormone 1alpha,25-dihydroxyvitamin D3 is associated with cycling of corepressors and histone deacetylases. J Mol Biol (2010) 0.92
Paricalcitol in dialysis patients with calcitriol-resistant secondary hyperparathyroidism. Am J Kidney Dis (2001) 0.92
Dairy product intake and its association with body weight and cardiovascular disease risk factors in a population in dietary transition. J Am Coll Nutr (2011) 0.91
Negative regulation of the human atrial natriuretic peptide gene by 1,25-dihydroxyvitamin D3. J Biol Chem (1994) 0.90
1,25-dihydroxyvitamin D3 reduces systolic blood pressure in hypertensive adults: a pilot feasibility study. J Steroid Biochem Mol Biol (2010) 0.90
Suppression of parathyroid hormone secretion in hemodialysis patients: comparison of paricalcitol with calcitriol. Am J Kidney Dis (2001) 0.89
Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis. Kidney Int (2007) 0.89
Effect of calcium supplementation on serum cholesterol and blood pressure. A randomized, double-blind, placebo-controlled, clinical trial. Arch Fam Med (2000) 0.88